BAKER BROTHERS INVESTMENTS

Asset Manager

Founded in Hidden

  1. dHidden
  2. gHidden
  3. oHidden
  1. Headcount: Hidden
  2. Assets Under Management: Hidden

Headquarters

Point of Contact

Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors

Baker and Kelvin M. Neu, M.D., joined its Board of Directors, effective March 10, 2014. Founded in 2000, Baker Brothers Investments manages long-term investment funds focused on publicly traded life sciences companies, for major university endowments and ...

Read More >
Business Wire
March 12, 2014
Report

Report inappropriate or irrelevant content

J&J, Pfizer chip in on $18M round for anti-inflammatory biotech's PhII

Pfizer Venture Investments joined a group of venture groups to provide a $25 million Series B round. And this new round includes new investor Augment Investments, Ventures West Capital, and Baker Brothers Investments.

Read More >
Fierce Biotech
April 2, 2013
Report

Report inappropriate or irrelevant content

Alexion Pharma to buy Synageva BioPharma for $8.4 billion

The deal provides a windfall for Synageva shareholders, particularly Baker Brothers Investments, which own about 32% of the company. The firm stands to make $2.68 billion from the transaction. Alexion's sole product on the market, Soliris, raked in $2.23 ...

Read More >
RTE Online
May 6, 2015
Report

Report inappropriate or irrelevant content

Alexion to pay $8.4B for Mass. drug maker

In connection with the deal, Felix Baker of Baker Brothers Investments, which along with its affiliates owns more than one-third of Synageva's stock, will join Alexion's board of directors. Alexion is slated to move its headquarters to New Haven later this ...

Read More >
Hartford Business
May 5, 2015
Report

Report inappropriate or irrelevant content

Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2

In our first article covering The Baker Brothers LLC's investments, we listed a few stocks the investment firm holds significant positions in. The Bakers have really done well over the last couple of years, and we see no reason why their stellar record ...

Read More >
Seeking Alpha
December 30, 2013
Report

Report inappropriate or irrelevant content

Baker Brothers Investments receives securities of ConjuChem Biotechnologies Inc. in connection with a Plan of Arrangement

Investments II, L.P., 667, L.P., Baker Brothers Life Sciences, L.P., 14159, L.P. and Baker/Tisch Investments, L.P. (Collectively, "Baker Brothers Investments") today announced that, pursuant to a plan of arrangement (the "Plan of Arrangement") under ...

Read More >
CNW Group
August 26, 2009
Report

Report inappropriate or irrelevant content

Vancouver-Based Biotech Company Aquinox Pharmaceuticals Files for $57.5 Million IPO

The financing was led by Ventures West Capital Ltd. and included new investors, Johnson & Johnson Development Corporation (JJDC) and Baker Brothers Investments. The company's existing investor, BC Advantage Funds (VCC) Ltd., managed by Lions Capital Corp ...

Read More >
T-Net British Columbia
January 29, 2014
Report

Report inappropriate or irrelevant content

Baker Brothers Investments receives securities of ConjuChem

Investments II, L.P., 667, L.P., Baker Brothers Life Sciences, L.P., 14159, L.P. and Baker/Tisch Investments, L.P. (Collectively, "Baker Brothers Investments") today announced that, pursuant to a plan of arrangement (the "Plan of Arrangement") under ...

Read More >
Bloomberg
January 22, 1987
Report

Report inappropriate or irrelevant content

Alexion Pharma (ALXN) to Acquire Synageva BioPharma (GEVA) for $230/Share

In connection with the Transaction, Synageva shareholders, including affiliates of Baker Brothers Investments, have entered into voting and support agreements with Alexion covering approximately 33.5% of Synageva’s outstanding shares. Alexion has ...

Read More >
StreetInsider
May 6, 2015
Report

Report inappropriate or irrelevant content

Alexion to Acquire Synageva for $8.4 billion

Strensiq is designed to restore the genetically defective ... Shareholders of Synageva, including affiliates of Baker Brothers Investments, have agreed to exchange about 33.5% of Synageva’s outstanding shares with Alexion, which has received $3.5 billion ...

Read More >
Genetic Engineering & Biotechnology News
May 6, 2015
Report

Report inappropriate or irrelevant content

Julian C. Baker

Mr. Baker serves as Managing Partner at Baker Brothers Investments. Mr. Baker served as Executive Director of Corporate Affairs at Idera Pharmaceuticals, Inc. until January 2015. He served as a Managing Partner of Baker Brothers Investments. Mr. Baker co ...

Read More >
Bloomberg
August 24, 2015
Report

Report inappropriate or irrelevant content

Felix J. Baker Ph.D.

Dr. Felix J. Baker, Ph.D. serves as the Managing Partner of Baker Brothers Investments and Baker-Tisch Investments. Dr. Baker co-founded Baker Brothers Investments in 2000. Dr. Baker serves as a Managing Member of Baker Bros. Advisors, L.L.C. and Baker ...

Read More >
Bloomberg
August 4, 2015
Report

Report inappropriate or irrelevant content

Idera Pharma (IDRA) Appoints Two Baker Brothers Nominees to Board

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced that Baker Brothers Investments’ Julian C. Baker and Kelvin M. Neu, M.D., joined its Board of Directors, effective March 10, 2014. Founded in 2000, Baker Brothers Investments manages long-term ...

Read More >
StreetInsider
March 12, 2014
Report

Report inappropriate or irrelevant content

DBV Technologies Announces the Appointment of Michael J. Goller to its Board of Directors

Goller has been appointed to its Board of Directors effective October 21, 2015. Mr. Goller is a Managing Director of Baker Brothers Investments, DBV's largest shareholder. Mr. Goller has been appointed to the Board of Directors to replace Dr. Rafaèle ...

Read More >
GlobeNewswire
October 21, 2015
Report

Report inappropriate or irrelevant content

One Reason Idera Pharmaceuticals (IDRA) Stock is Up Today

Julian Baker, a member of the company's board of directors and co-founder of hedge fund Baker Brothers Investments, purchased 5,333,333 shares of Idera on Friday at a price of $3.75 a share for a total transaction value of $19,999,998.75. Idera announced ...

Read More >
The Street
February 17, 2015
Report

Report inappropriate or irrelevant content

Idera shares spike on $20M stock purchase by board member

Baker, a a co-founder and managing partner of Baker Brothers Investments, was appointed to the board in March 2014. The firm manages long-term investment funds focused on publicly traded life sciences companies for major university endowments and foundations.

Read More >
The Business Journal
February 17, 2015
Report

Report inappropriate or irrelevant content

Big bucks for peanuts

DBV’s primary shareholders at an undiluted basis are Sofinnova Partners (14%), Bpifrance (13%), Baker Brothers Investments (6%) and CEO Pierre-Henri Benhamou (4%). If the immunotherapy company is successful in its bid, it will have a fully diluted market ...

Read More >
european-biotechnology-news.com
October 20, 2014
Report

Report inappropriate or irrelevant content

Peanut allergy biotech DBV Technologies sets terms for $98 million US IPO

Primary shareholders include Sofinnova Partners (14% pre-IPO stake), Bpifrance (13%), Baker Brothers Investments (6%) and CEO Pierre-Henri Benhamou (4%). DBV Technologies, which was founded in 2002 and booked $7 million in revenue for the 12 months ended ...

Read More >
NASDAQ
October 15, 2014
Report

Report inappropriate or irrelevant content

The Daily Startup: Aquinox Pharma Funded as COPD Therapies Attract Investors

Return investor Johnson & Johnson Development led the round, which also included new investor Augment Investments Ltd. and return backers Baker Brothers Investments, Pfizer Venture Investments and Ventures West Capital. Ignition Partners has closed on $150 ...

Read More >
The Wall Street Journal
April 4, 2013
Report

Report inappropriate or irrelevant content

No news for BAKER BROTHERS INVESTMENTS right now. Check back soon!
Powered by
Loading...
Loading...